As survival at 22 to 25 weeks’ gestation improves, the conversation in neonatology is shifting from “Can these infants survive?” to “What does long-term health look like?” The latest longitudinal research shows that infants born at the limits of viability are reaching childhood, adolescence, and even adulthood in greater numbers, but many continue to face elevated risks across neurodevelopmental, pulmonary, and metabolic domains.
Neurodevelopment: Better Survival, Persistent Risk
Recently, population-based follow-up studies have shown meaningful gains in survival without severe disability, particularly in centers using active perinatal intervention. In particular, a Swedish national cohort published in 2025 compared infants born at 22–26 weeks across two eras (2004–2007 vs. 2014–2016) and found improved developmental outcomes at 2–2.5 years, with lower rates of moderate-to-severe neurodevelopmental impairment in the more recent cohort. These findings suggest that advances in ventilation, nutrition, neuroprotection, and family-centered developmental care may be translating into measurable functional gains.
At the same time, long-term risk remains substantial. A large U.S. cohort study of 10,877 extremely preterm infants followed to 22–26 months found that approximately half had mild or no neurodevelopmental impairment, while roughly one in five had severe impairment. Rates of cerebral palsy, sensory impairment, and need for mobility or developmental supports remained significantly higher than in term-born peers. Outcomes were strongly associated with gestational age, with infants born at 22–23 weeks facing the highest risk. Furthermore, earlier school-age follow-up data demonstrated that by 6.5 years, extremely preterm children remained more likely to experience cognitive, motor, and executive-function challenges despite improvements in survival.
Respiratory Outcomes: Chronic Lung Disease Still Matters
For infants born at the edge of viability, respiratory morbidity continues to shape long-term outcomes. Bronchopulmonary dysplasia (BPD) remains one of the most common complications of extreme prematurity, and survivors frequently require rehospitalization, inhaled therapies, or pulmonary follow-up into childhood.
A 2024 multicenter study from the NICHD Neonatal Research Network examined infants born before 27 weeks and evaluated respiratory outcomes at two years. Researchers found that while physiologic testing methods such as room-air challenge may refine BPD classification, test results alone did not reliably predict later respiratory morbidity or neurodevelopmental impairment. This suggests that long-term pulmonary outcomes are influenced by a broader combination of neonatal exposures, inflammation, growth, and post-discharge care.
Additionally, other longitudinal cohorts continue to report increased rates of wheezing disorders, reduced lung function, exercise intolerance, and asthma-like symptoms into adolescence among survivors of extreme prematurity.
Metabolic Outcomes: An Emerging Adult Health Concern
Perhaps the most rapidly evolving area of research involves metabolic programming. Follow-up studies of adults born extremely prematurely suggest higher rates of insulin resistance, altered body composition, elevated blood pressure, and dyslipidemia compared with term-born controls.
Researchers are increasingly linking these outcomes to early postnatal growth patterns and neonatal nutritional stress. For example, a 2024 cohort study found that growth trajectories in extremely preterm infants, including delayed recovery of birth weight, were associated with later neurodevelopmental outcomes and may also reflect underlying metabolic vulnerability. Microbiome and metabolomic studies further suggest that infants with postnatal growth failure show altered nutrient metabolism early in life, raising questions about whether NICU nutrition strategies could influence cardiometabolic health decades later.
What Recent Findings Mean for NICU and Follow-Up Teams
The evidence is increasingly clear: for preterm infants, survival is only the beginning. Infants born at the limits of viability require coordinated, long-term surveillance that extends beyond infancy and into childhood, adolescence, and potentially adulthood. Developmental screening, pulmonary monitoring, nutrition management, and early family intervention are becoming essential components of care. For clinicians, the latest data offer both encouragement and responsibility: While outcomes are improving, long-term multidisciplinary follow-up remains critical to helping these children reach their fullest potential.
Part of fulfilling your role as an NNP to your best ability relies on a work environment where you can thrive. If you’re considering a career change, allow Ensearch to help match you with the best NICU for you. Get started with a free career consultation today.
